Patent application number | Description | Published |
20090163497 | Compounds Useful as Antagonists of CCR2 -
The present invention provides compounds of general formula (I) or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R | 06-25-2009 |
20090197884 | Compounds Useful as Antagonists of CCR2 - The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions. | 08-06-2009 |
20100016289 | Compounds Useful as Antagonists of CCR2 - The present invention provides compounds of general formula I: (I) or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R | 01-21-2010 |
20100093713 | BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE - This invention provides beta-carboline compounds of formula | 04-15-2010 |
20100179126 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 07-15-2010 |
20110237601 | Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists - The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: | 09-29-2011 |
20110257157 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 10-20-2011 |
20120208818 | COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 - The present invention provides compounds of general formula I: | 08-16-2012 |
20120214807 | COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 - The present invention provides compounds of general formula I: | 08-23-2012 |
20120302551 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 11-29-2012 |
20120309743 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 12-06-2012 |
20130123270 | SUBSTITUTED PIPERAZINYL-PYRROLIDINE COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS - The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: | 05-16-2013 |
20130217682 | PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME - Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I: | 08-22-2013 |
20140088096 | PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME - Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I: | 03-27-2014 |
20140194410 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 07-10-2014 |
20140364420 | SUBSTITUTED PIPERAZINYL-PYRROLIDINE COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS - The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: | 12-11-2014 |